Healthcare - Biotechnology - NASDAQ - US
$ 0.6142
-4.72 %
$ 3 M
Market Cap
-0.05
P/E
Price Target
Average
388.44%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
50.80%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Virpax Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for VRPX of $3 , with forecasts ranging from a low of $3 to a high of $3 .
VRPX Lowest Price Target
Wall Street Target
3 USD
388.44%
VRPX Average Price Target
Wall Street Target
3 USD
388.44%
VRPX Highest Price Target
Wall Street Target
3 USD
388.44%
REVENUE FORECAST
Revenue Forecast Chart VRPX
EBIT FORECAST
EBIT Forecast Chart VRPX
NET INCOME FORECAST
Net Income Chart VRPX